1290 Essex Small Cap Growth Fund Class A ESCFX

Morningstar Medalist Rating
  • NAV / 1-Day Return $17.54  /  +0.63 %
  • Fund Size $109.8M
  • Adjusted Expense Ratio 1.130%
  • Net Expense Ratio 1.130%
  • Fee Level: Distribution Below Average
  • Share Class Type Front Load
  • Morningstar Category Small Growth
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $1,000
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 55%

Morningstar’s Analysis ESCFX

Will ESCFX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

1290 Essex Small Cap Growth A holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ESCFX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 19.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Kiniksa Pharmaceuticals International PLC Class A

2.74 3M
Healthcare

Adaptive Biotechnologies Corp

2.45 3M
Healthcare

JPMorgan Prime Money Market IM

2.33 3M
Cash and Equivalents

CECO Environmental Corp

2.24 3M
Industrials

Travere Therapeutics Inc Ordinary Shares

1.97 2M
Healthcare

Leonardo DRS Inc

1.96 2M
Industrials

Oceaneering International Inc

1.72 2M
Energy

BrainsWay Ltd ADR

1.72 2M
Healthcare

Tower Semiconductor Ltd

1.57 2M
Technology

Lincoln Educational Services Corp

1.52 2M
Consumer Defensive

Sponsor Center